Next Article in Journal
The Yin-Yang of DNA Damage Response: Roles in Tumorigenesis and Cellular Senescence
Next Article in Special Issue
Melatonin May Curtail the Metabolic Syndrome: Studies on Initial and Fully Established Fructose-Induced Metabolic Syndrome in Rats
Previous Article in Journal
Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress
Int. J. Mol. Sci. 2013, 14(2), 2410-2430; doi:10.3390/ijms14022410
Review

Melatonin Anticancer Effects: Review

1,* , 1
, 2
 and 2
Received: 5 December 2012; in revised form: 14 January 2013 / Accepted: 15 January 2013 / Published: 24 January 2013
(This article belongs to the Special Issue Advances in the Research of Melatonin)
View Full-Text   |   Download PDF [747 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Melatonin (N-acetyl-5-methoxytryptamine, MLT), the main hormone produced by the pineal gland, not only regulates circadian rhythm, but also has antioxidant, anti-ageing and immunomodulatory properties. MLT plays an important role in blood composition, medullary dynamics, platelet genesis, vessel endothelia, and in platelet aggregation, leukocyte formula regulation and hemoglobin synthesis. Its significant atoxic, apoptotic, oncostatic, angiogenetic, differentiating and antiproliferative properties against all solid and liquid tumors have also been documented. Thanks, in fact, to its considerable functional versatility, MLT can exert both direct and indirect anticancer effects in factorial synergy with other differentiating, antiproliferative, immunomodulating and trophic molecules that form part of the anticancer treatment formulated by Luigi Di Bella (Di Bella Method, DBM: somatostatin, retinoids, ascorbic acid, vitamin D3, prolactin inhibitors, chondroitin-sulfate). The interaction between MLT and the DBM molecules counters the multiple processes that characterize the neoplastic phenotype (induction, promotion, progression and/or dissemination, tumoral mutation). All these particular characteristics suggest the use of MLT in oncological diseases.
Keywords: melatonin; apoptosis; angiogenesis; APUD system; Di Bella Method melatonin; apoptosis; angiogenesis; APUD system; Di Bella Method
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Di Bella, G.; Mascia, F.; Gualano, L.; Di Bella, L. Melatonin Anticancer Effects: Review. Int. J. Mol. Sci. 2013, 14, 2410-2430.

AMA Style

Di Bella G, Mascia F, Gualano L, Di Bella L. Melatonin Anticancer Effects: Review. International Journal of Molecular Sciences. 2013; 14(2):2410-2430.

Chicago/Turabian Style

Di Bella, Giuseppe; Mascia, Fabrizio; Gualano, Luciano; Di Bella, Luigi. 2013. "Melatonin Anticancer Effects: Review." Int. J. Mol. Sci. 14, no. 2: 2410-2430.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert